Search research articles
Contact Us
Filters
Showing results (11-20 of 83) with videos related to
Page
of 9
Sort By:
The Netherlands Journal of Medicine
|
April 1, 1994
What is the prevalence of clinical diabetic nephropathy?
T W van Haeften, A M Tegzess
European Journal of Clinical Investigation
|
April 17, 2004
Insulin-like growth factors and pancreas beta cells
T W van Haeften, Th B Twickler
Drugs
|
August 1, 1995
Prevention of complications in non-insulin-dependent diabetes mellitus (NIDDM)
B H Wolffenbuttel, T W van Haeften
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme
|
April 1, 1989
DIDMOAD syndrome and HLA-DR haplotypes
T W van Haeften, P P Razenberg
Clinical Chemistry
|
June 1, 1989
Arginine pharmacokinetics in humans assessed with an enzymatic assay adapted to a centrifugal analyzer
T W van Haeften, C H Konings
Lancet (London, England)
|
September 19, 2003
Diabetic environment in utero and predisposition to type 2 diabetes
T W van Haeften, T B Twickler
Nederlands Tijdschrift Voor Geneeskunde
|
November 25, 1989
[Determination of fasting blood glucose and serum fructosamine levels for the assessment of glucose regulation in patients with non-insulin dependent diabetes mellitus]
T W van Haeften, S M Walstra, C Rustemeijer
The Netherlands Journal of Medicine
|
July 4, 1998
The newly developed sulfonylurea glimepiride: a new ingredient, an old recipe
T F Veneman, C J Tack, T W van Haeften
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme
|
July 18, 2001
Gliclazide mainly affects insulin secretion in second phase of type 2 diabetes mellitus
J J Ligtenberg, W D Reitsma, T W van Haeften
The Netherlands Journal of Medicine
|
September 1, 1994
Acute pancreatitis in a patient with familial benign hypercalcaemia
T W van Haeften, K Hoogenberg, L H van Essen
Page
of 9
Search research articles
Search
Showing results (11-20 of 83) with videos related to
Sort By:
Page
of 9
The Netherlands Journal of Medicine
|
April 1, 1994
What is the prevalence of clinical diabetic nephropathy?
T W van Haeften, A M Tegzess
European Journal of Clinical Investigation
|
April 17, 2004
Insulin-like growth factors and pancreas beta cells
T W van Haeften, Th B Twickler
Drugs
|
August 1, 1995
Prevention of complications in non-insulin-dependent diabetes mellitus (NIDDM)
B H Wolffenbuttel, T W van Haeften
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme
|
April 1, 1989
DIDMOAD syndrome and HLA-DR haplotypes
T W van Haeften, P P Razenberg
Clinical Chemistry
|
June 1, 1989
Arginine pharmacokinetics in humans assessed with an enzymatic assay adapted to a centrifugal analyzer
T W van Haeften, C H Konings
Lancet (London, England)
|
September 19, 2003
Diabetic environment in utero and predisposition to type 2 diabetes
T W van Haeften, T B Twickler
Nederlands Tijdschrift Voor Geneeskunde
|
November 25, 1989
[Determination of fasting blood glucose and serum fructosamine levels for the assessment of glucose regulation in patients with non-insulin dependent diabetes mellitus]
T W van Haeften, S M Walstra, C Rustemeijer
The Netherlands Journal of Medicine
|
July 4, 1998
The newly developed sulfonylurea glimepiride: a new ingredient, an old recipe
T F Veneman, C J Tack, T W van Haeften
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme
|
July 18, 2001
Gliclazide mainly affects insulin secretion in second phase of type 2 diabetes mellitus
J J Ligtenberg, W D Reitsma, T W van Haeften
The Netherlands Journal of Medicine
|
September 1, 1994
Acute pancreatitis in a patient with familial benign hypercalcaemia
T W van Haeften, K Hoogenberg, L H van Essen
Page
of 9